Medicared For All Logo

Megan Tillman in Dothan, Alabama

Home Alabama Dothan

Megan Tillman has Nurse Practitioner as her primary medical specialty. Their primary office is: 287 Healthwest Dr in Dothan, Alabama.

They're a part of the: Dothan Hematology And Oncology, P. C. medical group which has around 13 members. You can call their office at 334-792-9500 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2016 (around 8 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Megan W Tillman Office Phone and Directions

Megan Tillman
Dothan Hematology And Oncology, P. C.
287 Healthwest Dr
Dothan, Alabama 36303
334-792-9500


Patient Ratings
Please rate your experience with Megan Tillman below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 334-792-9500


Enter a starting address:


Healthcare Info for Megan Tillman

Medical School: Sorry, her university is not listed
Graduation Year: 2016
The Primary Medical Specialty for Megan Tillman is listed as: Nurse Practitioner
Approximate Years of Experience: 8
PAC (PECOS ID)#: 9931484375
NPI #: 1982141107
NPI Created On: 01/25/2017
NPI Last Updated Listed as: 01/25/2017
Primary Taxonomy Code: 363LF0000X
License Number:
1-131459
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Complete blood cell count (red cells, white blood cell, platelets), automated test
  2. New patient office or other outpatient visit, typically 30 minutes
  3. Established patient office or other outpatient visit, typically 15 minutes
  4. Established patient office or other outpatient, visit typically 25 minutes
  5. Physician telephone patient service, 11-20 minutes of medical discussion
  6. Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788886867

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788886869

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788886871

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781025221

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781025223

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819366645

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ALIMTA

Open Associated Drug #1: 0002-7623-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: CYRAMZA

Associated Drug #2: 0002-7669-01

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819383617

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819383619

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819383623

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819391157

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ALIMTA

Open Associated Drug #1: 0002-7623-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: CYRAMZA

Associated Drug #2: 0002-7669-01

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60


Nurse Practitioner Professionals in Dothan

4370 W Main St
Dothan, AL
App Of Alabama Ed Pllc

4370 W Main St
Dothan, AL
Wiregrass Clinic Llc

4300 W Main St
Dothan, AL
Wiregrass Clinic Llc

1812 E Main St
Dothan, AL
Houston County Healthcare Authority

1146 Ross Clark Cir
Dothan, AL
Southeast Cardiology Clinic Inc.

4370 W Main St
Dothan, AL
Wiregrass Clinic Llc

Providers in Dothan Hematology And Oncology, P. C.

1.Candice Bertsch

287 Healthwest Dr
Dothan Al 36303-2031
Dothan Hematology And Oncology, P. C.
Nurse Practitioner

2.Jawanunna Blackmon

287 Healthwest Dr
Dothan Al 36303-2031
Dothan Hematology And Oncology, P. C.
Hematology/oncology

3.John Dunn

287 Healthwest Dr
Dothan Al 36303-2031
Dothan Hematology And Oncology, P. C.
Hematology/oncology

4.Cara Hinckley

287 Healthwest Dr
Dothan Al 36303-2031
Dothan Hematology And Oncology, P. C.
Nurse Practitioner

5.Michael Mcallister Md

287 Healthwest Dr
Dothan Al 36303-2031
Dothan Hematology And Oncology, P. C.
Hematology/oncology

6.Allison Mcallister

287 Healthwest Dr
Dothan Al 36303-2031
Dothan Hematology And Oncology, P. C.
Nurse Practitioner

View all 13 members of Dothan Hematology And Oncology, P. C. medical group